| Antimicrobial resistance in aquaculture: Current knowledge and alternatives to tackle the problem |
71 |
| Antibacterial and antifungal properties of resveratrol |
37 |
| Bacteriophage Sb-1 enhances antibiotic activity against biofilm, degrades exopolysaccharide matrix and targets persisters of Staphylococcus aureus |
32 |
| Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience |
24 |
| Plant nutraceuticals as antimicrobial agents in food preservation: terpenoids, polyphenols and thiols |
24 |
| Non-prescription sales of antimicrobial agents at community pharmacies in developing countries: a systematic review |
23 |
| Resistance to fosfomycin: Mechanisms, Frequency and Clinical Consequences |
23 |
| Antibiotic discovery: history, methods and perspectives |
22 |
| In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-beta-lactamase-producing isolates (SIDERO-WT-2014 Study) |
22 |
| 16-membered macrolide antibiotics: a review |
21 |
| Dalbavancin in the treatment of different gram-positive infections: a real-life experience |
21 |
| In Vitro Activity of Cefiderocol, a Siderophore Cephalosporin, Against Gram-Negative Bacilli Isolated by Clinical Laboratories in North America and Europe in 2015-2016: SIDERO-WT-2015 |
21 |
| Co-occurrence of mcr- mcr-4 and mcr-5 genes in multidrug-resistant ST10 Enterotoxigenic and Shiga toxin-producing Escherichia coli in Spain (2006-2017) |
20 |
| High prevalence of 16S rRNA methyltransferases among carbapenemase-producing Enterobacteriaceae in the UK and Ireland |
20 |
| Bacteriophage therapy as an alternative treatment for human infections. A comprehensive review |
18 |
| Antibacterial and antivirulence activities of auranofin against Clostridium difficile |
18 |
| Association between augmented renal clearance, antibiotic exposure and clinical outcome in critically ill septic patients receiving high doses of beta-lactams administered by continuous infusion: a prospective observational study |
17 |
| Rapid emergence of highly variable and transferable oxazolidinone and phenicol resistance gene optrA in German Enterococcus spp. clinical isolates |
17 |
| Adjunctive therapy with azithromycin for moderate and severe acute respiratory distress syndrome: a retrospective, propensity score-matching analysis of prospectively collected data at a single center |
17 |
| Control of Candida auris in healthcare institutions: Outcome of an International Society for Antimicrobial Chemotherapy expert meeting |
16 |
| Is antimicrobial administration to food animals a direct threat to human health? A rapid systematic review |
16 |
| Current antifungal treatment of fusariosis |
15 |
| The dosing and monitoring of vancomycin: what is the best way forward? |
15 |
| Rare mould infections caused by Mucorales, Lomentospora prolificans and Fusarium, in San Diego, CA: the role of antifungal combination therapy |
15 |
| Panton-Valentine leukocidin-positive Staphylococcus aureus: a position statement from the International Society of Chemotherapy |
15 |
| In-vitro activity of the novel fluorocycline eravacycline against carbapenem non-susceptible Acinetobacter baumannii |
15 |
| Emergence of NDM-5-producing Escherichia coli sequence type 167 clone in Italy |
15 |
| Role of association of OmpK35 and OmpK36 alteration and bla(ESBL) and/or bla(AmpC) genes in conferring carbapenem resistance among non-carbapenemase-producing Klebsiella pneumoniae |
14 |
| Detection and characterization of methicillin-resistant and susceptible coagulase-negative staphylococci in milk from cows with clinical mastitis in Tunisia. |
14 |
| Clonal emergence of Klebsiella pneumoniae ST14 co-producing OXA-48-type and NDM carbapenemases with high rate of colistin resistance in Dubai, United Arab Emirates |
14 |
| Reactive oxygen species: a novel antimicrobial |
14 |
| The prevalence of colistin resistance in Escherichia coli and Klebsiella pneumoniae isolated from food animals in China: coexistence of mcr-1 and bla(NDM) with low fitness cost |
14 |
| Synergistic interactions of sulfamethoxazole and azole antifungal drugs against emerging multidrug-resistant Candida auris |
14 |
| Genomic analysis of multidrug-resistant Escherichia coli ST58 causing urosepsis |
13 |
| Host defense cathelicidins in cattle: types, production, bioactive functions and potential therapeutic and diagnostic applications |
12 |
| In vitro activity of meropenem/vaborbactam and characterisation of carbapenem resistance mechanisms among carbapenem-resistant Enterobacteriaceae from the 2015 meropenem/vaborbactam surveillance programme |
12 |
| Bacteraemia due to extensively drug-resistant Pseudomonas aeruginosa sequence type 235 high-risk clone: Facing the perfect storm |
12 |
| In situ antimicrobial behavior of materials with copper-based additives in a hospital environment |
12 |
| Integrons in Enterobacteriaceae: diversity, distribution and epidemiology |
12 |
| Infections by multidrug- resistant Gram-negative Bacteria: What's new in our arsenal and what's in the pipeline? |
12 |
| The value of anticoccidials for sustainable global poultry production |
12 |
| The chemotherapeutic potential of chalcones against leishmaniases: a review |
12 |
| Clinical relevance of metronidazole and peripheral neuropathy: a systematic review of the literature |
12 |
| Carbapenems and alternative beta-lactams for the treatment of infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae: What impact on intestinal colonisation resistance? |
12 |
| Carbapenem and colistin resistance in Enterobacteriaceae in Southeast Asia: Review and mapping of emerging and overlapping challenges |
11 |
| The antifungal arsenal: alternative drugs and future targets |
11 |
| Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection |
11 |
| Imported poultry meat as a source of extended-spectrum cephalosporin-resistant CMY-2-producing Salmonella Heidelberg and Salmonella Minnesota in the European Union, 2014-2015 |
11 |
| Repurposing niclosamide for intestinal decolonization of vancomycin-resistant enterococci |
11 |
| The comparative efficacy of antiseptics against Candida auris biofilms |
11 |
